Selecta Biosciences Email Format

Biotechnology ResearchMassachusetts, United States11-50 Employees

Selecta Biosciences is a clinical-stage biopharmaceutical company focused on therapies designed to modulate immune responses to treat and prevent disease. Its work emphasizes targeted immunotherapies and vaccines intended to influence the immune system selectively, addressing rare and serious conditions. The company is based in Watertown, Massachusetts, and operates within the biotechnology research industry with a relatively small team.

Selecta's approach rests on a proprietary platform known as Synthetic Vaccine Particle (SVP), which underpins its immune-modulation efforts. In November 2023 the company announced the acquisition of Cartesian Therapeutics, a Gaithersburg-based developer focused on autoimmune diseases. This move reflects ongoing activity in the sector as Selecta pursues development of therapies that aim to achieve targeted immune tolerance.

Sign up for free to view info

Company overview Employee directory